Anti‐CTLA4 monoclonal antibodies plus chemotherapy vs chemotherapy alone
Toxicity (≥ G3) · people with cutaneous melanoma
Anti‐CTLA4 monoclonal antibodies plus chemotherapy probably leads to higher toxicity (≥ G3) compared with chemotherapy (moderate certainty).
1 finding from 1 review
- RR 1.69 [1.19, 2.42]1142 participantsModerate